Abstract:Objective:To investigate the relationship between hepatic venous pressure gradient (HVPG) and parameters of Doppler ultrasound in patients with pyrroidine alkaloid-related hepatic sinusoidal obstruction syndrome (PA-HSOS).Methods:From February 17, 2017 to April 22, 2020, the clinical data of 68 patients with PA-HSOS who underwent HVPG manometry and Doppler ultrasound examination at Drum Tower Hospital, the Affiliated Medical College of Nanjing University were retrospectively analyzed, which included HVPG, Drum Tower severity scoring (DTSS), time from PA-HSOS related symptoms appeared to diagnosis after taking pyrroidine alkaloid (hereinafter referred to as diagnosis time), and parameters of Doppler ultrasound induding portal vein trunk diameter (PD), peak portal vein velocity (PPV), splenic vein trunk diameter (SD) and peak splenic vein velocity (PSV). Receiver operating characteristic curve (ROC) was used to determine the optimal cut-off value of HVPG for predicting non-response to anticoagulation therapy. Binary logistic regression was used to analyze the independent risk factors for non-response to anticoagulation therapy, and Kaplan-Meier survival curve was used to analyze the prognostic survival rate of patients with different HVPG levels. Unitary linear regression was applied to analyze the correlation of HVPG with PD, PPV, SD and PSV in patients with different HVPG levels, patients with mild, moderate and severe DTSS, and patients with diagnosis time >1 month or ≤ 1 month. Chi-square test was used for statistical analysis.Results:The results of ROC analysis showed that the optimal cut-off value of HVPG for predicting non-response to anticoagulant therapy was 20.165 mmHg(1 mmHg=0.133 kPa). The result of multivariate analysis indicated that high HVPG (HVPG>20.165 mmHg) was an independent risk factor for predicting non-response to anticoagulant therapy ( OR (95% confidence interval)=6.039(1.466 to 24.869), P=0.013). Kaplan-Meier survival curve demonstrated that prognostic survival rate of patients with high HVPG was lower than that of patients with low HVPG (HVPG≤20.165 mmHg) (78.4% vs.96.8%), and the difference was statistically significant( χ2=4.74, P=0.030). The results of unitary linear regression analysis showed that there was a negative correlation between HVPG and PPV in 68 patients with PA-HSOS( r=-0.330, P=0.006); HVPG was positively correlated with PD and SD in patients with high HVPG ( r=0.540 and 0.341, P=0.001 and 0.039); there was a negative correlation between HVPG and PSV in patients with mild DTSS ( r=-0.519, P=0.019), HVPG was negatively correlated with PPV in patients with moderate DTSS ( r=-0.400, P=0.014). In patients with diagnosis time ≤1 month, there was a negative correlation between HVPG and PPV ( r=-0.391, P=0.010). Conclusions:HVPG can assist in judging the response to anticoagulation therapy and the prognosis of patients with PA-HSOS. Parameters of Doppler ultrasound can help to assess the degree of HVPG elevation in patients with PA-HSOS under certain conditions.

Traditional Chinese Medicine Containing Pyrrolizidine Alkaloids and Hepatic Veno-Occlusive Disease

Clinical Analysis of 50 Cases of Hepatic Veno-Occlusive Disease

Clinical Analysis of Hepatic Veno-Occlusive Disease Induced by Sedum Aizoon

Hepatic Veno-Occlusive Disease Induced by Gymura Segetum: Report of Two Cases

Mo1436 - Clinical Characteristics and Treatment of Pyrrolizidine Alkaloid-Related Hepatic Vein Occlusive Disease

Clinical analysis on gynura segetum induced hepatic veno-occlusive disease

Clinical and pathologic study on hepatic veno-occlusive disease

Hepatic Sinusoidal Obstruction Syndrome Caused by the Ingestion of Gynura Segetum in a Patient with Alcoholic Cirrhosis: a Case Report.

Clinical Characteristics and Outcomes of Patients with Hepatic Veno-Occlusive Disease Induced by Gynura Segetum: A Retrospective Study

CT Imaging of Hepatic Veno-occlusive Disease Caused by Gynura Segetum

[Clinical Characteristics of Hepatic Veno-Occlusive Disease in 6 Children with Hematologic Neoplasm Treated with 6-Thioguanine].

Treatment for Gynura Segetum Caused Hepatic Vein Occlusive Disease: a Single-Center Retrospective Study

Prognostic Risk Factors for Patients with Hepatic Sinusoidal Obstruction Syndrome Caused by Pyrrolizidine Alkaloids

Definitive Diagnosis of Hepatic Sinusoidal Obstruction Syndrome Induced by Pyrrolizidine Alkaloids.

The value of hepatic venous pressure gradient in patients with pyrrolidine alkaloid-induced hepatic sinusoidal obstruction syndrome

CT venography in diagnosis of hepatic veno occlusive disease induced by aedum aizoon

Relationship between hepatic venous pressure gradient and parameters of Doppler ultrasound in 68 patients with pyrroidine alkaloid-related hepatic sinusoidal obstruction syndrome

Hepatobiliary and pancreatic: Comparison between Chinese herbal medicine and Western medicine-induced liver injury of 1985 patients.

Blood Pyrrole-Protein Adducts As A Diagnostic and Prognostic Index in Pyrrolizidine Alkaloid-Hepatic Sinusoidal Obstruction Syndrome

Drug-induced hepatitis due to oral traditional Chinese medicine decoction

Preliminary study of the changes in blood system in pyrrolizidine alkaloid-related liver damage